Bausch & Lomb Goes Private Under $4.5 Bil. Warburg Pincus Buyout
This article was originally published in The Gray Sheet
Executive Summary
Ophthalmic device firm Bausch & Lomb's acceptance of a $4.5 billion private equity buyout offer from Warburg Pincus leaves the door open for a higher bid by early July, according to B&L
You may also be interested in...
News In Brief
Obama signs appropriations bill giving FDA expanded user fee access. Bausch & Lomb IPO. More news.
Lifecore Set To Go Private Under $239 Million Warburg Pincus Buyout Deal
Dental implant maker Lifecore Biomedical is on-track to be acquired by private equity firm Warburg Pincus for $239 million after failing to receive a superior proposal, the firm said Feb. 14
Lifecore Set To Go Private Under $239 Million Warburg Pincus Buyout Deal
Dental implant maker Lifecore Biomedical is on-track to be acquired by private equity firm Warburg Pincus for $239 million after failing to receive a superior proposal, the firm said Feb. 14